Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation

L. Fan, H. L. Benson, R. Vittal, E. A. Mickler, R. Presson, A. Jo Fisher, O. W. Cummings, K. M. Heidler, M. R. Keller, W. J. Burlingham, D. S. Wilkes

Research output: Contribution to journalArticle

107 Scopus citations


Obliterative bronchiolitis (OB) is the key impediment to the long-term survival of lung transplant recipients and the lack of a robust preclinical model precludes examining OB immunopathogenesis. In the current study, lungs from C57BL/10 H-2b mice that are MHC compatible, but minor histocompatability antigen incompatible, were transplanted into C57BL/6 mice. Histological features and cytokine profiles of OB were assessed. Moderate rejection (grade A3) developed by day 14, with evidence of OB at that time point. At 21 days, OB was present in 55% of grafts and moderate to severe rejection (grade A3-A4) was present in all mice. At 28 days, OB was present in 44% of mice and severe rejection (grade A4) was present in all. IL-17A, but not IL-17F, splenic mRNA transcripts and serum protein levels were increased only in mice that developed OB, whereas IL-10 transcripts and protein were increased only in non-OB mice. Neutralizing IL-17 prevented OB, down regulated acute rejection, and upregulated systemic IL-10. Collectively, these data show that transplantation of minor histoincompatible lungs from C57BL/10 mice into C57BL/6 mice results in a highly reproducible preclinical model of OB. In addition, these data indicate that neutralizing IL-17A or augmenting IL-10 could be therapeutic interventions to prevent OB.

Original languageEnglish (US)
Pages (from-to)911-922
Number of pages12
JournalAmerican Journal of Transplantation
Issue number5
StatePublished - May 2011


  • IL-17
  • Lung transplantation
  • mouse
  • obliterative bronchiolitis

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation'. Together they form a unique fingerprint.

  • Cite this

    Fan, L., Benson, H. L., Vittal, R., Mickler, E. A., Presson, R., Fisher, A. J., Cummings, O. W., Heidler, K. M., Keller, M. R., Burlingham, W. J., & Wilkes, D. S. (2011). Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. American Journal of Transplantation, 11(5), 911-922.